Drugmaker GSK profit rockets on consumer health spinoff | ABS-CBN
ADVERTISEMENT

Welcome, Kapamilya! We use cookies to improve your browsing experience. Continuing to use this site means you agree to our use of cookies. Tell me more!
Drugmaker GSK profit rockets on consumer health spinoff
Drugmaker GSK profit rockets on consumer health spinoff
Agence France-Presse
Published Nov 02, 2022 04:38 PM PHT

LONDON - British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profit rocketed almost ten-fold to £10.3 billion ($11.5 billion) on the blockbuster spinoff of consumer healthcare division Haleon.
LONDON - British drugmaker GlaxoSmithKline said Wednesday that third-quarter net profit rocketed almost ten-fold to £10.3 billion ($11.5 billion) on the blockbuster spinoff of consumer healthcare division Haleon.
Earnings after taxation spiked in the three months to the end of September from a year earlier, due to a total gain of £9.6 billion on the Haleon demerger, GSK said in a results statement.
Earnings after taxation spiked in the three months to the end of September from a year earlier, due to a total gain of £9.6 billion on the Haleon demerger, GSK said in a results statement.
RELATED VIDEO:
RELATED VIDEO:
ADVERTISEMENT
ADVERTISEMENT